Pharmacology of Vasoconstrictors - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Pharmacology of Vasoconstrictors

Description:

... Patient is in a hyperthyroid state of observable distress 7) ... Management of cardiac arrest 4) ... Length of the dental procedure 2) ... – PowerPoint PPT presentation

Number of Views:1103
Avg rating:3.0/5.0
Slides: 36
Provided by: rusty3
Category:

less

Transcript and Presenter's Notes

Title: Pharmacology of Vasoconstrictors


1
Pharmacology of Vasoconstrictors
2
  • What happens if you dont use a vasoconstrictor?
  • Plain local anesthetics are vasodilators by
    nature
  • 1) Blood vessels in the area dilate
  • 2) Increase absorption of the local anesthetic
    into the
  • cardiovascular system (redistribution)
  • 3) Higher plasma levels ? increased risk of
    toxicity
  • 4) Decreased depth and duration of anesthesia ?
    diffusion
  • from site
  • 5) Increased bleeding due to increased blood
    perfusion to the
  • area

3
  • 1) Patient is not numb as long without
  • epinephrine
  • 2) Patient is simply not as numb
  • 3) More anesthetic goes into the circulation
  • 4) Increased bleeding more blood to area

4
Why You Need Vasoconstrictors
  • Vasoconstrictors resemble adrenergic drugs and
    are called
  • sympathomimetic, or adrenergic drugs
  • 1) Constrict blood vessels ? decrease blood
    flow to the surgical site
  • 2) Cardiovascular absorption is slowed ? lower
    anesthetic blood levels
  • 3) Local anesthetic blood levels are lowered ?
    lower risk of toxicity
  • 4) Local anesthetic remains around the nerve for
    longer periods ?
  • increased duration of anesthesia
  • 5) Decreases bleeding

5
Chemical Structure
  • Classification of Adrenergic Drugs
  • Classification by chemical structure is related
    to the presence or absence of a catechol nucleus
  • Catechol is orthodihydroxybenezene
  • Sympathomimetic drugs that have a hydroxy (OH-)
    substitution in the 3rd and 4th positions of the
    aromatic ring are termed catechols

6
Catecholamines
  • If the 3rd and 4th positions contain an amine
    group (NH2) attached to
  • the aliphatic side chain, they are then called
    catecholamines
  • Epinephrine
  • Norepinephrine natural
    catecholamines of sympathetic NS
  • Dopamine
  • Isoproterenol
  • and synthetic
    catecholamine
  • Levonordefrin

7
Chemical Structure
  • Catecholamines Noncatecholamines
  • Epinephrine Amphetamine
  • Norepinephrine Methamphetamine
  • Levonordefrin Ephedrine
  • Isoproterenol Mephentermine
  • Dopamine Hydroxyamphetamine
  • Metaraminol
  • Methoxamine
  • Phenylephrine
  • Felypressin ? synthetic analogue of vasopressin
    (ADH) not in U.S.

8
Modes of Action
  • 3 Classes of Sympathomimetic Amines
  • 1)Direct Acting ? directly on adrenergic
    receptors
  • 2) Indirect Acting ? use norepinephrine
    release
  • 3) Mixed Acting ? both direct and indirect
    actions

9
  • 2 Types of Adrenergic Receptors
  • 1) Alpha
  • -contraction of smooth muscle in
    blood vessels
  • -vasoconstriction
  • -Alpha 1 ? excitatory post-synaptic
  • -Alpha 2 ? inhibitory post-synaptic
  • 2) Beta
  • -smooth muscle relaxation
  • -vasodilation/bronchodilation
  • -cardiac stimulation, i.e., increased
  • rate and strength of contraction

10
  • 2 Types of Beta Receptors
  • 1) Beta 1
  • -found in heart and small intestines
  • -produces cardiac stimulation and lipolysis
  • 2) Beta 2
  • -found in bronchi of the lung, vascular beds
  • and uterus
  • -produces bronchodilation and vasodilation

11
(No Transcript)
12
  • The dilution of vasoconstrictors is commonly
    referred to as a ratio i.e., 150,000 1100,000
    1200,000 etc,
  • A concentration of 11,000 means that there is 1
    gram
  • (1000 mg) of solute (drug) contained in 1000 ml
    (1 L) of
  • solution, therefore, 11,000 dilution contains
    1000 mg
  • in 1000 ml or 1.0 mg/ml of solution (1000 ug/ml)
  • The concentration of 11,000 is very concentrated
  • (strong) a much more dilute form is used in
    dentistry
  • for example, 150,000 gt 1100,000 gt 1200,000
  • (1100,000 0.01 mg/1 ml of solution)

13
(No Transcript)
14
  • per 1.8 ml cartridge of anesthetic
  • 150,000 .036 mg epinephrine
  • 1100,000 .018 mg epinephrine
  • 1200,000 .009 mg epinephrine
  • decreasing potency of epinephrine

15
  • 150,000 epinephrine is used to stop bleeding
    in a
  • surgical area this amount of epinephrine is
    not used
  • for block anesthesia
  • 1) Bleeding areas that require resin from any
    trauma
  • 2) Nick the papilla with a bur resin or alloy
  • 3) Oral surgery root tip removal bloody socket
  • 4) Works awesome for short period of time
  • 5) Use as alternative to electrosurgery unit

16
  • Resting plasma epinephrine levels are doubled
    when one cartridge of 2 Lidocaine 1100,000
    epinephrine is injected
  • Recent evidence suggests that epinephrine plasma
    levels equivalent to those achieved during
    moderate to heavy exercise occur after intraoral
    injection
  • Moderate increase in cardiac output and stroke
    volume occurs
  • Blood pressure and heart rate are minimally
    affected
  • IV administration of .015 mg of epinephrine with
    Lidocaine can increase heart rate 25 to 75 beats
    and increase systolic blood pressure 20 to 70
    mmHg
  • Epinephrine reaction causes tachycardia,
    sweating, apprehension
  • and pounding in the chest (palpitations)

17
Norepinephrine
18
  • NOREPINEPHRINE
  • Norepinephrine lacks Beta 2 actions
    (bronchodilation and vasodilation) and produces
    intense peripheral vasoconstriction with possible
    dramatic elevations in blood pressure
  • Norepinephrines side effect ratio is 9 times
    higher than epinephrine
  • Norepinephrines use in dentistry is not
    recommended and its use is diminishing around the
    world
  • Epinephrine remains the vasopressor of choice in
    dentistry
  • Norepinephrine is not used because of its many
    side effects

19
Epinephrine
20
Epinephrine
  • Sodium Bisulfite antioxidant added
  • 18 months shelf life
  • Acts directly on Alpha and Beta receptors
  • Beta effects predominate
  • Increases force / rate of contraction
  • Increases stroke volume
  • Increases myocardial O2 use
  • Increases cardiac output / heart rate
  • Increases dysrhythmias and PVCs
  • Increases coronary artery perfusion
  • Increases systolic blood pressure
  • Decrease in cardiac efficiency

21
  • Alpha receptor stimulation leads to hemostasis
    initially
  • Beta 2 actions predominate leading to
    vasodilation 6 hours after a surgical procedure
  • Potent bronchodilator (asthma)
  • Not a potent CNS stimulant
  • Increases oxygen consumption in all tissues of
    the body
  • Reuptake by adrenergic nerves terminates
    epinephrine action
  • Ventricular fibrillation is possible

22
(No Transcript)
23
  • 1.8 ml Cartridge of 2 Lidocaine 1100,000 epi
  • Maximum Epinephrine 11 Cartridges
  • Maximum Anesthetic 300 mg
  • 1.8 ml Cartridge of 2 Lidocaine 1200,000 epi
  • Maximum Epinephrine 22 Cartridges
  • Maximum Anesthetic 300 mg

24
  • The maximum amount of 2 Lidocaine 1100,000
    epinephrine that can be used is 300 mg which is
    8.3 cartridges regardless of the patients
    weight so the maximum epinephrine will only be
    achieved after you have already surpassed the
    maximum amount of anesthetic allowable
  • 8.3 cartridges

25
  • American Heart Association says that the
  • typical concentrations of vasoconstrictors
  • in local anesthetics are not contraindicated
  • in patients with cardiovascular disease so
  • long as aspiration, slow injection and the
  • smallest effective dose is administered
  • ASA III and ASA IV pose the largest risk

26
How much Epinephrine in CV patients?
  • Maximum Epinephrine
  • .04 mg
  • Two cartridges of 1100,000 epinephrine

27
  • Clinical Applications of Epinephrine
  • 1) Management of acute allergic reactions
  • 2) Management of bronchospasm
  • 3) Management of cardiac arrest
  • 4) Vasoconstrictor for hemostasis
  • 5) Vasoconstrictor to decrease absorption into
    CVS
  • 6) Vasoconstrictor to increase depth of
    anesthesia
  • 7) Vasoconstrictor to increase duration of
    anesthesia
  • 8) To produce mydriasis (excessive pupil
    dilation)

28
Levonordefrin
29
  • Levonordefrin is freely soluble in dilute acid
    solutions
  • Sodium bisulfite is added to delay its
    deterioration
  • Synthetic vasoconstrictor
  • Acts through direct Alpha receptor stimulation
    (75)
  • Acts through some Beta activity (25)

30
  • Levonordefrin produces less cardiac and CNS
    stimulation than epinephrine
  • Levonordefrin is eliminated via COMT
    (catechol-O-methyl transferase) and MAO (monamine
    oxidase)
  • Levonordefrin is obtained via Mepivacaine
    120,000 used at a higher concentration, i.e.,
    120,000 because it is
  • 1/6th as potent as epinephrine
  • Levonordefrin has a maximum recommended dose of
    11 cartridges

31
  • -Levonordefrin is only 1/6th as strong as
    Epinephrine, therefore, using a ratio of 120,000
    Levonordefrin is like using a ratio of 1120,000
    of Epinephrine
  • -you will need more Levonordefrin because it is
    only 15 as effective as Epinephrine

32
  • 2 vasoconstrictors are available in North
    America
  • 1) Epinephrine
  • 2) Levonordefrin
  • Selection of a vasoconstrictor depends on
  • 1) Length of the dental procedure
  • 2) Requirement for hemostasis
  • 3) Requirement for post-operative pain control
  • 4) Medical status of the patient

33
(No Transcript)
34
Contraindications to Using Vasoconstrictors
  • 1) Blood pressure gt 200/115 mm Hg
  • 2) Severe cardiovascular disease ASA IV
  • 3) Acute myocardial infarction in the last 6
    months
  • 4) Anginal episodes at rest
  • 5) Cardiac dysrhythmias that are refractory to
    drug treatment
  • 6) Patient is in a hyperthyroid state of
    observable distress
  • 7) Levonordefrin and Norepinephrine are
    absolutely
  • contraindicated in patients taking
    tricyclic antidepressants
  • (Elavil, Sinequan)

35
References
  • Malamed, Stanley Handbook of Local Anesthesia.
    5th Edition. Mosby. 2004
Write a Comment
User Comments (0)
About PowerShow.com